Literature DB >> 2166897

Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166897

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
  6 in total

1.  Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.

Authors:  W J Driskell; D L Ashley; J Grainger; S R Sirimanne; E P Mazzola; S W Page; L L Needham; R H Hill
Journal:  Bull Environ Contam Toxicol       Date:  1992-05       Impact factor: 2.151

2.  Eosinophilic Fasciitis associated with Mycoplasma arginini infection.

Authors:  Pálma Silló; Dóra Pintér; Eszter Ostorházi; Mercedes Mazán; Norbert Wikonkál; Katinka Pónyai; Dmitriy V Volokhov; Vladimir E Chizhikov; Susan Szathmary; Laszlo Stipkovits; Sarolta Kárpáti
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

3.  Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats.

Authors:  J Adachi; M Gomez; C C Smith; E M Sternberg
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.

Authors:  J Adachi; K Yamamoto; Y Ogawa; Y Ueno; Y Mizoi; Y Tatsuno
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.

Authors:  R H Hill; S P Caudill; R M Philen; S L Bailey; W D Flanders; W J Driskell; M L Kamb; L L Needham; E J Sampson
Journal:  Arch Environ Contam Toxicol       Date:  1993-07       Impact factor: 2.804

6.  Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome.

Authors:  J Adachi; T Naito; Y Ueno; Y Ogawa; I Ninomiya; Y Tatsuno
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.